Novo Nordisk A/S stock price
NVO
#65

44,21 $
  

0.58%

Novo Nordisk A/S Info

Capitalización de mercado
195,82B $

0.58%

Volumen diario
472,27M $
Tipo de activo
Acciones
Empleados
78387
Fundado
Dec 21, 1923
Exchange principal
New York Stock Exchange
Número CIK
0000353278

Datos de acciones tokenizadas

Prom. del precio tokenizado
45 $
Diferencia de precio
+0,7891 $(+1.78%)
Capitalización de mercado tokenizada
33,17M $

2.04%

Volumen tokenizado (24h)
1,32M $

3.75%

Emisores
Contratos
Exploradores
Convertidor de NVO a USD
NVO
USD
Rendimiento de precios
Baja
43,4 $
Alta
44,57 $

Cargando datos

Por favor, espera, estamos cargando datos de gráficos

Novo Nordisk A/S comunidad

skeleton-white
 
 
 
 
 
 

About Novo Nordisk A/S

What is Novo Nordisk A/S?

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk A/S Datos de Precio en vivo

The current price of Novo Nordisk A/S in the market is 44,21 $, with a 24-hour trading volume of 472,27M $. The asset's market cap is 195,82B $, after moving 0.58% in the last day.

Tokenized Novo Nordisk A/S is trading at 45 $, with a tokenized market cap of 33,17M $ and a 24-hour trading volume of 1,32M $. The tokenized asset has moved 2.04% in the past 24 hours.